These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide. Ikenoue T; Okazaki K; Fujitani S; Tsuchiya Y; Akiyoshi M; Maki T; Kondo N Biol Pharm Bull; 1997 Apr; 20(4):354-9. PubMed ID: 9145209 [TBL] [Abstract][Full Text] [Related]
8. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide. Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of insulin release in hereditarily diabetic rats by mixed molecules formed of nateglinide and a succinic acid ester. Ladriere L; Bjorkling F; Malaisse WJ Int J Mol Med; 2000 Jan; 5(1):63-5. PubMed ID: 10601576 [TBL] [Abstract][Full Text] [Related]
10. Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats. Mori Y; Kitahara Y; Miura K; Mine T; Tajima N Diabetes Obes Metab; 2004 Nov; 6(6):422-31. PubMed ID: 15479218 [TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide. Hu S; Wang S; Dunning BE Int J Exp Diabetes Res; 2001; 2(1):63-72. PubMed ID: 12369728 [TBL] [Abstract][Full Text] [Related]
12. Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action. Hu S Eur J Pharmacol; 2002 May; 442(1-2):163-71. PubMed ID: 12020694 [TBL] [Abstract][Full Text] [Related]
14. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. Tuomi T; Honkanen EH; Isomaa B; Sarelin L; Groop LC Diabetes Care; 2006 Feb; 29(2):189-94. PubMed ID: 16443858 [TBL] [Abstract][Full Text] [Related]
15. Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs. Okamoto M; Ogihara N; Kawamura W; Ebihara S; Takiguchi K; Morita T; Uchida R; Yamaguchi J; Sakai T; Okuda Y; Hayashi Y; Arakawa Y; Kikuchi M Metabolism; 2002 May; 51(5):575-81. PubMed ID: 11979388 [TBL] [Abstract][Full Text] [Related]
16. Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177 [TBL] [Abstract][Full Text] [Related]
17. Effects of the methyl esters of pyruvate, succinate and glutamate on the secretory response to meglitinide analogues in rat pancreatic islets. Bakkali Nadi A; Zhang TM; Malaisse WJ Pharmacol Res; 1996 Mar; 33(3):191-4. PubMed ID: 8880890 [TBL] [Abstract][Full Text] [Related]
18. Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes. Kitahara Y; Miura K; Takesue K; Mine T; Wada R; Uchida Y; Ito S; Yagihashi S Metabolism; 2002 Nov; 51(11):1452-7. PubMed ID: 12404197 [TBL] [Abstract][Full Text] [Related]
19. Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. Kahn SE; Montgomery B; Howell W; Ligueros-Saylan M; Hsu CH; Devineni D; McLeod JF; Horowitz A; Foley JE J Clin Endocrinol Metab; 2001 Dec; 86(12):5824-9. PubMed ID: 11739446 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide. Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]